ARCHIVES

Program Monitors Resistance In Antimicrobial And Antifungal Therapies for Cancer Patients

This article is from The Cancer Letter archive.

Vol. 25 No. 11 | November 29, 2002

Download PDF Visit The Full Archive

Related Articles

Historical Vs. Current Controls: Comparability, Ethical Issues Argued By Moertel, Freireich

April 20, 1979

Phase III Study Evaluating Halaven Fails To Meet Primary Endpoints

July 27, 2012

New NIH Program To Develop Therapies For Rare, Neglected Diseases

June 19, 2009

New Treatment Approach To Treating Brain Tumor

April 26, 2002

New Staff Proposals For Comprehensive Center Recognition Considered By NCAB

January 19, 1979

Study Reveals Racial Disparities In Surgical Prostate Care

August 31, 2012